booster dose
Covaxin proven safe for children of 2-18 years age group in phase III study: Bharat Biotech
Covaxin safe, well-tolerated in 2-18 years age-group: Bharat Biotech
89 per cent of India's adult population fully vaccinated against COVID-19: Mandaviya
India shows exemplary resilience in recovery from COVID-19 crisis: CEA
/newsdrum-in/media/agency_attachments/2025/01/29/2025-01-29t072616888z-nd_logo_white-200-niraj-sharma.jpg)
/newsdrum-in/media/post_banners/x9ExAR1l68oCCpJtpXN6.jpg)
/newsdrum-in/media/post_banners/Rqb3i4SCJ2RA8SlidYb6.jpg)
/newsdrum-in/media/post_banners/3wvZhxjcuGu0eQxQd7bt.jpg)
/newsdrum-in/media/post_banners/bhigOVfWPVLY5uMH5Unz.jpg)
/newsdrum-in/media/post_banners/ShAmsIoAc2aiAZBiJ316.jpg)
/newsdrum-in/media/post_banners/gRtX6WZvGETc8QGl4cQa.jpg)
/newsdrum-in/media/post_banners/cbHfG4SE21amd7imMxrc.jpg)
/newsdrum-in/media/post_banners/06WUgi3ieabMO0w3x7cT.jpg)
/newsdrum-in/media/post_banners/J5fZ8rXVpWkeg3gKlqCT.jpg)
/newsdrum-in/media/post_banners/Kc7QRf6luyUgymN3gwTL.jpg)
